AbCellera Biologics Inc vs Clorox Co — how do they compare? AbCellera Biologics Inc trades at $9.21 (market cap $2.99B), while Clorox Co trades at $106.99 (market cap $13.09B). The key difference: Clorox Co is far larger — about 4.4× AbCellera Biologics Inc's market cap, and Clorox Co pays a 4.62% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | CLX | |
|---|---|---|
Market Cap | $2.99B | $13.09B |
Sector | Health | Consumer Staples |
52-Week High | $9.76 | $127.16 |
52-Week Low | $2.78 | $86.12 |
Enterprise Value | $2.58B | $18.47B |
Dividend Yield | — | 4.62% |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →With a history dating back more than 100 years, Clorox now plays in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just shy of 85% of Clorox's sales stem from its home turf.
Read more on CLX →